Filing Details

Accession Number:
0001209191-22-010952
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-17 18:10:06
Reporting Period:
2022-02-16
Accepted Time:
2022-02-17 18:10:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720580 Adicet Bio Inc. ACET Pharmaceutical Preparations (2834) 813305277
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1823901 Aya Jakobovits C/O Adicet Bio, Inc.
200 Clarendon Street, Floor 6
Boston MA 02116
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-16 2,000 $14.83 358,343 No 4 S Indirect See Footnote
Common Stock Disposition 2022-02-16 2,000 $14.83 358,345 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 138,076 Indirect See Footnote
Footnotes
  1. These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.52 to $15.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
  4. Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
  5. Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.